Difference between revisions of "Serous carcinoma of the fallopian tube"
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
'''Serous carcinoma of the fallopian tube''' is a [[serous carcinoma]] that arise from the [[Fallopian tube]]. These are thought to be important in the development of [[ovarian cancer]].<ref>{{cite journal |authors=Samuel D, Diaz-Barbe A, Pinto A, Schlumbrecht M, George S |title=Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2 |journal=Cells |volume=11 |issue=3 |pages= |date=February 2022 |pmid=35159349 |pmc=8834207 |doi=10.3390/cells11030539 |url=}}</ref> | '''Serous carcinoma of the fallopian tube''' is a [[serous carcinoma]] that arise from the [[Fallopian tube]]. These are thought to be important in the development of [[ovarian cancer]].<ref name=pmid35159349>{{cite journal |authors=Samuel D, Diaz-Barbe A, Pinto A, Schlumbrecht M, George S |title=Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2 |journal=Cells |volume=11 |issue=3 |pages= |date=February 2022 |pmid=35159349 |pmc=8834207 |doi=10.3390/cells11030539 |url=}}</ref> | ||
==General== | |||
May be associated with germline mutations in:<ref name=pmid35159349>{{cite journal |authors=Samuel D, Diaz-Barbe A, Pinto A, Schlumbrecht M, George S |title=Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2 |journal=Cells |volume=11 |issue=3 |pages= |date=February 2022 |pmid=35159349 |pmc=8834207 |doi=10.3390/cells11030539 |url=}}</ref> | |||
*BRCA1. | |||
*BRCA2. | |||
*ATM. | |||
*PALB2. | |||
*[[BRIP1]]. | |||
==Microscopic== | ==Microscopic== |
Revision as of 05:15, 4 November 2024
Serous carcinoma of the fallopian tube is a serous carcinoma that arise from the Fallopian tube. These are thought to be important in the development of ovarian cancer.[1]
General
May be associated with germline mutations in:[1]
- BRCA1.
- BRCA2.
- ATM.
- PALB2.
- BRIP1.
Microscopic
Images
See also
References
- ↑ 1.0 1.1 Samuel D, Diaz-Barbe A, Pinto A, Schlumbrecht M, George S (February 2022). "Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2". Cells 11 (3). doi:10.3390/cells11030539. PMC 8834207. PMID 35159349. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834207/.